Company intelligence / Profile preview

Vitameter

Waterloo, Ontario, Canadapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Preclinical

Overview

Vitameter developed a handheld diagnostic device capable of determining an individual's vitamin levels from a single drop of blood. The user experience was designed to be similar to that of current glucose meters. The company participated in Bayer's Grants4Apps accelerator program in Germany in 2015 and returned to Canada after the program. There is no evidence the product reached commercial launch or regulatory approval[1][3][7].

Therapeutic areas: Metabolic DisordersOther
Modalities: Device (handheld diagnostic device)
Industry: Metabolite Diagnostics

Partnerships

Bayer HealthCare Grants4Apps Accelerator

Beyond the preview

Go deeper on Vitameter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitameter.

Explore the full profile